Oklahoma Medical Research Foundation:製薬・医療:M&Aディール及び事業提携情報

【英語タイトル】Oklahoma Medical Research Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C9348)・商品コード:DATA904C9348
・発行会社(調査会社):GlobalData
・発行日:2018年11月
・ページ数:59
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Oklahoma Medical Research Foundation (OMRF) is a non-profit biomedical research institute. The institute conducts disease research for human diseases such as lupus, alzheimer’s and diseases of aging, diabetics, cancer, children’s disease, autoimmune disease and heart diseases. Its portfolio of research programs includes Cell Cycle and Cancer Biology Research Program, Aging and Metabolism Research Program, and Cardiovascular Biology Research Program, Functional and Chemical Genomics Research Program, among others. OMRF’s Technology Ventures seeks to work in partnership with other organizations to develop and commercialize the technologies. The institute also provides graduate education programs that include the scholarships and mentoring for doctoral students. OMRF is headquartered in Oklahoma City, Oklahoma, the US.

Oklahoma Medical Research Foundation – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Oklahoma Medical Research Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Oklahoma Medical Research Foundation, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Oklahoma Medical Research Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Oklahoma Medical Research Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Oklahoma Medical Research Foundation, Medical Devices Deals, 2012 to YTD 2018 10
Oklahoma Medical Research Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Oklahoma Medical Research Foundation, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Otologic Pharma Raises US$4.1 Million In Series A Financing 12
Oklahoma Medical Research Raises US$1 Million In Seed Financing 13
Partnerships 14
Oklahoma Medical Research Foundation Enters into Agreement with GlaxoSmithKline 14
Q BioMed Enters into Agreement with Oklahoma Medical Research Foundation and Rajiv Gandhi Centre for Biotechnology 15
Eisai Enters into Research Agreement with Oklahoma Medical Research Foundation 16
Progentec Diagnostics Enters into Agreement with Oklahoma Medical Research Foundation 17
Licensing Agreements 18
Shanghai RAAS Enters into Licensing Agreement with Oklahoma Medical Research 18
Q BioMed Enters into Licensing Agreement with Oklahoma Medical Research Foundation and Rajiv Gandhi Centre for Biotechnology 19
Xonovo Enters into Licensing Agreement with Oklahoma Medical Research Foundation 20
Asset Transactions 21
GtreeBNT Acquires Rights to OKN-007 from Oklahoma Medical Research Foundation 21
Oklahoma Medical Research Foundation – Key Competitors 22
Oklahoma Medical Research Foundation – Key Employees 23
Oklahoma Medical Research Foundation – Locations And Subsidiaries 26
Head Office 26
Recent Developments 27
Legal and Regulatory 27
Sep 13, 2017: OMRF Genomics Center earns CAP accreditation 27
Government and Public Interest 28
Aug 27, 2018: OMRF receives $1.4 million to study DNA errors in birth defects, diseases 28
Aug 23, 2018: OMRF receives $2.8 million grant to study rare disorder 29
Jul 30, 2018: Presbyterian Health Foundation awards $3.5 million in grants to OMRF, OUHSC 30
Jul 02, 2018: OMRF receives $2.1 million to study cell division 31
Apr 23, 2018: Experts propose improving clinical trials for lupus 32
Apr 18, 2018: Discovery Could Explain Cell Division Errors in Cancer 33
Apr 04, 2018: OMRF discovers new approach to treating obesity 34
Mar 19, 2018: OMRF discovery could lead to new therapies for MS 35
Feb 26, 2018: OMRF receives $2.25 million grant to study vision loss 36
Feb 08, 2018: OMRF postdoc receives national aging reward 37
Jan 15, 2018: The Kirschner Trusts award $6,000 grant to OMRF researcher 38
Dec 27, 2017: Rapp Foundation gives $400,000 to OMRF for new researchers 39
Dec 20, 2017: OMRF researchers identify genes that may cause cancer to recur after treatment 40
Nov 07, 2017: OMRF researcher receives Alzheimer’s grant 41
Oct 19, 2017: OMRF research shows how exercise can benefit cartilage 42
Oct 06, 2017: Putnam City donates $90,000 to cancer research at OMRF 43
Aug 08, 2017: OMRF receives four grants totaling more than $5 million 44
Aug 03, 2017: Findings yield new clues to puzzling autoimmune disease 45
Jul 26, 2017: Oklahoma researchers zero in on cause of blood disorder 46
Jul 19, 2017: International study reveals 24 new genes associated with lupus 47
Jul 17, 2017: Presbyterian Health Foundation awards more than $3.7 million in grants to OUHSC, OMRF 49
Jun 21, 2017: OMRF receives new grants to study blood clotting, ovarian cancer 50
May 18, 2017: Researchers identify gene associated with lupus 51
May 08, 2017: OMRF makes new findings related to colon cancer gene 52
Mar 16, 2017: OMRF receives grant to study triggers of cancer, birth defects 53
Feb 16, 2017: Researchers make new insights into birth defects, infertility 54
Jan 26, 2017: OMRF researcher receives rheumatology award 55
Jan 23, 2017: OMRF part of research team that receives $9 million aging grant 56
Jan 12, 2017: Hearst Foundations make grant to OMRF 57
Jan 03, 2017: OMRF receives federal grant to investigate cell death 58
Appendix 59
Methodology 59
About GlobalData 59
Contact Us 59
Disclaimer 59

List of Tables
Oklahoma Medical Research Foundation, Pharmaceuticals & Healthcare, Key Facts 2
Oklahoma Medical Research Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Oklahoma Medical Research Foundation, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Oklahoma Medical Research Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Oklahoma Medical Research Foundation, Deals By Therapy Area, 2012 to YTD 2018 9
Oklahoma Medical Research Foundation, Medical Devices Deals, 2012 to YTD 2018 10
Oklahoma Medical Research Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Otologic Pharma Raises US$4.1 Million In Series A Financing 12
Oklahoma Medical Research Raises US$1 Million In Seed Financing 13
Oklahoma Medical Research Foundation Enters into Agreement with GlaxoSmithKline 14
Q BioMed Enters into Agreement with Oklahoma Medical Research Foundation and Rajiv Gandhi Centre for Biotechnology 15
Eisai Enters into Research Agreement with Oklahoma Medical Research Foundation 16
Progentec Diagnostics Enters into Agreement with Oklahoma Medical Research Foundation 17
Shanghai RAAS Enters into Licensing Agreement with Oklahoma Medical Research 18
Q BioMed Enters into Licensing Agreement with Oklahoma Medical Research Foundation and Rajiv Gandhi Centre for Biotechnology 19
Xonovo Enters into Licensing Agreement with Oklahoma Medical Research Foundation 20
GtreeBNT Acquires Rights to OKN-007 from Oklahoma Medical Research Foundation 21
Oklahoma Medical Research Foundation, Key Competitors 22
Oklahoma Medical Research Foundation, Key Employees 23
Oklahoma Medical Research Foundation, Key Employees (cont..) 25

List of Figures
Oklahoma Medical Research Foundation, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Oklahoma Medical Research Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Oklahoma Medical Research Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Oklahoma Medical Research Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Oklahoma Medical Research Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Oklahoma Medical Research Foundation, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Oklahoma Medical Research Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Oklahoma Medical Research Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Oklahoma Medical Research Foundation, Medical Devices Deals, 2012 to YTD 2018 10

★調査レポート[Oklahoma Medical Research Foundation:製薬・医療:M&Aディール及び事業提携情報] (コード:DATA904C9348)販売に関する免責事項を必ずご確認ください。
★調査レポート[Oklahoma Medical Research Foundation:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆